Groups | Gender | Doubling time of the F3II mammary carcinoma (days) | |
---|---|---|---|
Before DC treatment | After DC treatment | ||
CG1 | M (N = 5) | 4.33 ± 0.92 | 6.00 ± 2.20 |
F (N = 5) | 4.27 ± 1.97 | 6.50 ± 1.06 | |
CG2 | M (N = 5) | 3.60 ± 0.93 | 3.20 ± 0.86 |
F (N = 5) | 2.00 ± 1.51 | 4.80 ± 1.02 | |
TG1 | M (N = 10) | 1.60 ± 0.59 | 5.60 ± 1.80 |
F (N = 10) | 4.25 ± 1.22 | 7.00 ± 1.18 | |
TG2 | M (N = 5) | 7.20 ± 2.35 | 11.20 ± 2.95a |
F (N = 6) | 5.17 ± 0.83 | 12.75 ± 2.35a | |
TG3 | M (N = 8) | 5.17 ± 1.28 | 7.00 ± 1.93 |
F (N = 5 | 3.75 ± 1.25 | 9.25 ± 2.02a | |
TG4 | M (N = 8) | 5.40 ± 1.72 | 6.20 ± 2.45 |
F (N = 7) | 5.80 ± 1.24 | 3.80 ± 0.58 | |
TG5 | M (N = 7) | 3.80 ± 0.37 | 5.40 ± 1.16 |
F (N = 5) | 3.75 ± 1.38 | 5.33 ± 1.45 | |
TG6 | M (N = 5) | 3.50 ± 2.51 | 5. 66 ± 4.01 |
F (N = 6) | 5.00 ± 1.45 | 15.40 ± 0.98a |